GLP-1 receptor agonists
AssessTechniques
A class of drugs that mimic GLP-1 to regulate appetite and metabolism.
Why it's here
Placed in Assess: 3 article(s) of evidence from 1 source(s), led by research-stage coverage, with 2 in the last 30 days. Confidence 38%.
Evidence (3)
- 6Hacker News·8/11/2026researchBrain weight-loss drugs may be nearing a breakthrough
The article argues that neuroscience could be approaching a GLP-1-like turning point, with new drugs or interventions potentially offering major benefits for brain-related conditions. It frames this as an emerging research area rather than a finished treatment, with evidence still developing and clinical impact yet to be proven.
- 6Hacker News·8/10/2026researchHarvard study finds GLP-1 drugs may boost women’s employment
A Harvard/NBER working paper reports that women who started GLP-1 weight-loss drugs while unemployed were about 27 percentage points more likely to be employed 18 months later than similar women who had not started treatment. The study suggests appearance-related bias may influence hiring and broader labor-market outcomes, rather than indicating any change in capability from the drugs themselves.
- 5Hacker News·6/27/2026researchOzempic May Affect Mood Through the Gut-Brain Axis
A reported study suggests GLP-1 drugs such as Ozempic and liraglutide may do more than support weight loss by also reducing depression-like behavior in mice. The effect appears to depend on gut microbes, especially Lactobacillus delbrueckii, which may produce endocannabinoids linked to stress reduction.